About Celsis
Celsis is a company based in Chicago (United States) founded in 1994 was acquired by BioIVT in July 2013.. Celsis has raised $36.8 million across 1 funding round from investors including BioIVT and Harwood Private Equity. Celsis operates in a competitive market with competitors including Evelo Biosciences, PathogenDX, AFYREN, Spore Biotechnologies and Perfectus Biomed, among others.
- Headquarter Chicago, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Celsis
Celsis has successfully raised a total of $36.8M through 1 strategic funding round. The most recent funding activity was a Series B round of $36.8 million completed in September 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $36.8M
-
First Round
First Round
(01 Sep 2009)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2009 | Amount | Series B - Celsis | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Celsis
Celsis has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include BioIVT and Harwood Private Equity. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Harwood Private Equity is focused on UK mid-market investments.
|
Founded Year | Domain | Location | |
|
Provider of in vitro diagnostic products and assay services
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Celsis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Celsis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Celsis Comparisons
Competitors of Celsis
Celsis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evelo Biosciences, PathogenDX, AFYREN, Spore Biotechnologies and Perfectus Biomed, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for inflammatory diseases, COVID-19, and cancer are developed.
|
|
| domain | founded_year | HQ Location |
Provider of DNA-based pathogen testing kits
|
|
| domain | founded_year | HQ Location |
Analytical services are provided for microbiology, chemistry, and bioprocesses sectors.
|
|
| domain | founded_year | HQ Location |
Microbial detection technology is developed for life science industries.
|
|
| domain | founded_year | HQ Location |
Provides services for research-based approach for microbiological testing
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Celsis
When was Celsis founded?
Celsis was founded in 1994 and raised its 1st funding round 15 years after it was founded.
Where is Celsis located?
Celsis is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Is Celsis a funded company?
Celsis is a funded company, having raised a total of $36.8M across 1 funding round to date. The company's 1st funding round was a Series B of $36.8M, raised on Sep 01, 2009.
What does Celsis do?
Celsis was founded in 1994 and is based in Chicago, United States. Operations focus on the biopharmaceutical and consumer products industries, where rapid microbial screening systems are produced for quality control. These systems are utilized in non-sterile and sterile applications to detect the presence or absence of contaminations, supporting compliance and safety standards across manufacturing processes.
Who are the top competitors of Celsis?
Celsis's top competitors include PathogenDX, AFYREN and Perfectus Biomed.
Who are Celsis's investors?
Celsis has 2 investors. Key investors include BioIVT, and Harwood Private Equity.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.